Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.12 - $2.18 $624 - $11,338
-5,201 Reduced 14.41%
30,896 $78,000
Q2 2022

Aug 12, 2022

BUY
$1.56 - $4.29 $55,348 - $152,209
35,480 Added 5750.41%
36,097 $73,000
Q4 2021

Feb 10, 2022

BUY
$6.99 - $9.39 $4,312 - $5,793
617 New
617 $5,000

About Renovacor, Inc.


  • Ticker RCOR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,267,700
  • Description
  • Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It primarily focuses on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy (DCM). T...
More about RCOR
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.